An important part of the Agency for Health Technology Assessment and Tariff System’s work is the assessment of medicines. The issued recommendations/positions and opinions concern mostly medicinal products. Medicine technologies are evaluated by the Agency under a commission of the Minister of Health.
The medicinal products assessment guidelines indicate how a medicine should be assessed:
- what each analysis should contain, and
- how they should be prepared.
Thanks to the guidelines, the quality of analyses is high and the reimbursement process is standardised for all medicines. This assures that a given assessment of a medicinal product is reliable.
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out.
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2021]